ORKA
Oruka Therapeutics, Inc.
94.60$
+1.3%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +145.3% | -37.8% | -49.8% | -44.8% | +25.1% | +490.8% | +8.9% | -21.6% | -12.1% | +946.0% | +23.4% | |
| – | +151.3% | -44.9% | -42.6% | -44.9% | +25.1% | +489.2% | +8.9% | -21.5% | -12.0% | +902.5% | -8.8% | |
| – | +152.7% | -80.9% | +17.6% | -24.1% | +26.6% | +486.8% | +8.7% | -20.5% | -11.8% | +64.5% | -23.8% | |
| – | +152.7% | -45.5% | -44.5% | -43.8% | +26.6% | +486.8% | +8.7% | -20.5% | -11.8% | +903.6% | -10.3% | |
| – | +8.1% | +61.9% | -14.2% | -62.1% | +16.8% | +322.0% | -0.7% | -63.6% | -40.4% | +1,540.7% | +20.9% | |
| – | +8.4% | +59.3% | -13.6% | -61.7% | +16.8% | +277.9% | 0.0% | -67.6% | -43.7% | +1,947.6% | +17.9% | |
| – | – | – | – | – | – | +64.0% | +143.9% | +3.0% | -26.2% | +180.3% | +190.6% | |
| – | – | – | – | -63.0% | +81.7% | +324.2% | -37.0% | -70.1% | – | – | +20.0% | |
| – | +158.3% | -41.7% | -53.7% | -41.3% | +26.2% | +511.3% | +9.7% | -18.4% | -11.2% | +932.5% | +23.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +114.7% | +44.2% | +15.0% | +32.8% | +71.7% | +4,178.1% | +195.2% | +3.6% | +0.0% | +16.5% | +171.7% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.